Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Quinazoline and quinazoline-like compounds for the treatment of integrin-mediated disorders

Quinazoline and quinazoline-like compounds for the treatment of integrin-mediated disorders

US Patent 7081460 · Granted Jul 25, 2006

Estimated economic value: $10,380,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Metalloenzyme inhibitor compounds2025
Treatment of EGFR mutant-related cancers using a combination of EGFR and CDK4/6 2025
Organophosphorus-substituted compounds as c-MET inhibitors and therapeutic uses 2025
Pharmaceutical formulations of N-(2-(2-(dimethylamino)ethoxy)-4-methoxy-5-((4-(12025
Monocyclic and bicyclic ring system substituted carbanucleoside analogues for us2024
6-6 bicyclic aromatic ring substituted nucleoside analogues for use as PRMT5 inh2024
Substituted 2-anilinopyrimidine derivatives as EGFR modulators2022
2H-indazole derivatives as CDK4 and CDK6 inhibitors and therapeutic uses thereof2022
6-6 bicyclic aromatic ring substituted nucleoside analogues for use as PRMT5 inh2022
Metalloenzyme inhibitor compounds2022
Pharmaceutical formulations of N-(2-(2-(dimethylamino) ethoxy)-4-methoxy-5-((4-(2021
Monocyclic and bicyclic ring system substituted carbanucleoside analogues for us2021